Avant Diagnostics (AVDX) Starts Presentation at LD Micro Main Event
Avant Diagnostics (OTC: AVDX) is a diagnostic company focused on the commercialization of a series of proprietary microarray-based diagnostic tests that provide early detection of cancers, neurodegenerative diseases, and other chronic and severe disease states. The company's product is OvaDxÒ, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer. For more information, visit the company's website at www.avantdiagnostics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW…